Celldex Therapeutics, Inc.
CLDX· Nasdaq
Released Nov 12, 2019, before the open
10-Q filed Nov 12, 2019, 43 days after period end · 0001104659-19-062181
| Metric | Q3 2019 | Q3 2018 | Q3 2017 | Q3 2016 |
|---|---|---|---|---|
| Revenue | $546.00K | $941.00K | $3.92M | $2.22M |
| EPS Diluted | -$0.75 | -$0.66 | -$3.05 | -$0.29 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Celldex Therapeutics, Inc. · CIK 744218 · Engraved from SEC EDGAR